• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

食管原发性小细胞癌的多组学分析揭示了 RB1 缺失和其他分子亚型。

Multi-omics profiling of primary small cell carcinoma of the esophagus reveals RB1 disruption and additional molecular subtypes.

机构信息

Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P. R. China.

Cancer Institute of the Affiliated Hospital of Qingdao University, Qingdao Cancer Institute, Qingdao, P. R. China.

出版信息

Nat Commun. 2021 Jun 18;12(1):3785. doi: 10.1038/s41467-021-24043-6.

DOI:10.1038/s41467-021-24043-6
PMID:34145257
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8213753/
Abstract

Primary small cell carcinoma of the esophagus (PSCCE) is a lethal neuroendocrine carcinoma. Previous studies proposed a genetic similarity between PSCCE and esophageal squamous cell carcinoma (ESCC) but provided little evidence for differences in clinical course and neuroendocrine differentiation. We perform whole-exome sequencing, RNA sequencing and immunohistochemistry profiling on 46 PSCCE cases. Integrated analyses enable the discovery of multiple mechanisms of RB1 disruption in 98% (45/46) of cases. The transcriptomic landscape of PSCCE closely resembles small cell lung cancer (SCLC) but differs from ESCC or esophageal adenocarcinoma (EAC). Distinct gene expression patterns regulated by ASCL1 and NEUROD1 define two molecular subtypes, PSCCE-A and PSCCE-N, which are highly similar to SCLC subtypes. A T cell excluded phenotype is widely observed in PSCCE. In conclusion, PSCCE has genomic alterations, transcriptome features and molecular subtyping highly similar to SCLC but distinct from ESCC or EAC. These observations are relevant to oncogenesis mechanisms and therapeutic vulnerability.

摘要

原发性食管小细胞癌(PSCCE)是一种致命的神经内分泌癌。先前的研究提出 PSCCE 与食管鳞状细胞癌(ESCC)之间存在遗传相似性,但对临床病程和神经内分泌分化的差异提供的证据很少。我们对 46 例 PSCCE 病例进行了全外显子组测序、RNA 测序和免疫组织化学分析。综合分析发现,98%(45/46)的病例存在 RB1 破坏的多种机制。PSCCE 的转录组图谱与小细胞肺癌(SCLC)非常相似,但与 ESCC 或食管腺癌(EAC)不同。由 ASCL1 和 NEUROD1 调控的不同基因表达模式定义了两个分子亚型,PSCCE-A 和 PSCCE-N,它们与 SCLC 亚型高度相似。在 PSCCE 中广泛观察到 T 细胞排斥表型。总之,PSCCE 具有与 SCLC 高度相似的基因组改变、转录组特征和分子亚型,但与 ESCC 或 EAC 不同。这些观察结果与肿瘤发生机制和治疗脆弱性有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4b0/8213753/98c6d54e1c47/41467_2021_24043_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4b0/8213753/9eb7966939cb/41467_2021_24043_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4b0/8213753/c4610c6a5db7/41467_2021_24043_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4b0/8213753/597faab141e5/41467_2021_24043_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4b0/8213753/21a565e6a45b/41467_2021_24043_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4b0/8213753/c866a1d6e243/41467_2021_24043_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4b0/8213753/98c6d54e1c47/41467_2021_24043_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4b0/8213753/9eb7966939cb/41467_2021_24043_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4b0/8213753/c4610c6a5db7/41467_2021_24043_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4b0/8213753/597faab141e5/41467_2021_24043_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4b0/8213753/21a565e6a45b/41467_2021_24043_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4b0/8213753/c866a1d6e243/41467_2021_24043_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4b0/8213753/98c6d54e1c47/41467_2021_24043_Fig6_HTML.jpg

相似文献

1
Multi-omics profiling of primary small cell carcinoma of the esophagus reveals RB1 disruption and additional molecular subtypes.食管原发性小细胞癌的多组学分析揭示了 RB1 缺失和其他分子亚型。
Nat Commun. 2021 Jun 18;12(1):3785. doi: 10.1038/s41467-021-24043-6.
2
Clinicopathological and genomic comparisons between different histologic components in combined small cell lung cancer and non-small cell lung cancer.联合型小细胞肺癌与非小细胞肺癌不同组织学成分的临床病理与基因组学比较。
Lung Cancer. 2018 Nov;125:282-290. doi: 10.1016/j.lungcan.2018.10.006. Epub 2018 Oct 9.
3
Comparative Molecular Analyses of Esophageal Squamous Cell Carcinoma, Esophageal Adenocarcinoma, and Gastric Adenocarcinoma.食管鳞癌、食管腺癌和胃腺癌的比较分子分析。
Oncologist. 2018 Nov;23(11):1319-1327. doi: 10.1634/theoncologist.2018-0143. Epub 2018 Jun 4.
4
SOX2 and Rb1 in esophageal small-cell carcinoma: their possible involvement in pathogenesis.食管小细胞癌中的SOX2和Rb1:它们可能在发病机制中的作用。
Mod Pathol. 2017 May;30(5):660-671. doi: 10.1038/modpathol.2016.222. Epub 2017 Jan 20.
5
Concurrent RB1 and TP53 Alterations Define a Subset of EGFR-Mutant Lung Cancers at risk for Histologic Transformation and Inferior Clinical Outcomes.同时存在 RB1 和 TP53 改变的 EGFR 突变型肺癌具有组织学转化和临床结局不良的风险。
J Thorac Oncol. 2019 Oct;14(10):1784-1793. doi: 10.1016/j.jtho.2019.06.002. Epub 2019 Jun 19.
6
Transformation to small cell lung cancer is irrespective of EGFR and accelerated by SMAD4-mediated ASCL1 transcription independently of RB1 in non-small cell lung cancer.非小细胞肺癌中转化为小细胞肺癌与 EGFR 无关,并且由 SMAD4 介导的 ASCL1 转录独立于 RB1 而加速。
Cell Commun Signal. 2024 Jan 17;22(1):45. doi: 10.1186/s12964-023-01260-8.
7
Comprehensive Genomic Profiling of Advanced Esophageal Squamous Cell Carcinomas and Esophageal Adenocarcinomas Reveals Similarities and Differences.晚期食管鳞状细胞癌和食管腺癌的综合基因组分析揭示异同
Oncologist. 2015 Oct;20(10):1132-9. doi: 10.1634/theoncologist.2015-0156. Epub 2015 Sep 2.
8
REST Inactivation and Coexpression of ASCL1 and POU3F4 Are Necessary for the Complete Transformation of RB1/TP53-Inactivated Lung Adenocarcinoma into Neuroendocrine Carcinoma.REST失活以及ASCL1和POU3F4的共表达是RB1/TP53失活的肺腺癌完全转化为神经内分泌癌所必需的。
Am J Pathol. 2022 Jun;192(6):847-861. doi: 10.1016/j.ajpath.2022.03.007. Epub 2022 Mar 30.
9
Application of Small Cell Lung Cancer Molecular Subtyping Markers to Small Cell Neuroendocrine Carcinoma of the Cervix: NEUROD1 as a Poor Prognostic Factor.应用小细胞肺癌分子分型标志物于宫颈小细胞神经内分泌癌:NEUROD1 作为不良预后因素。
Am J Surg Pathol. 2024 Mar 1;48(3):364-372. doi: 10.1097/PAS.0000000000002155. Epub 2023 Nov 20.
10
Next-Generation Sequencing of Pulmonary Large Cell Neuroendocrine Carcinoma Reveals Small Cell Carcinoma-like and Non-Small Cell Carcinoma-like Subsets.肺大细胞神经内分泌癌的下一代测序揭示了小细胞癌样和非小细胞癌样亚组。
Clin Cancer Res. 2016 Jul 15;22(14):3618-29. doi: 10.1158/1078-0432.CCR-15-2946. Epub 2016 Mar 9.

引用本文的文献

1
The impact of immunotherapy on the prognosis of small cell carcinoma of the esophagus: a propensity score-matched analysis of a retrospective study.免疫疗法对食管小细胞癌预后的影响:一项回顾性研究的倾向评分匹配分析
Front Immunol. 2025 Aug 22;16:1634834. doi: 10.3389/fimmu.2025.1634834. eCollection 2025.
2
Dissecting small cell carcinoma of the esophagus ecosystem by single-cell transcriptomic analysis.通过单细胞转录组分析剖析食管小细胞癌生态系统
Mol Cancer. 2025 May 15;24(1):142. doi: 10.1186/s12943-025-02335-5.
3
A novel risk stratification system for primary small-cell carcinoma of the esophagus: indication for prognostication and staging.

本文引用的文献

1
Whole-genome sequencing of 508 patients identifies key molecular features associated with poor prognosis in esophageal squamous cell carcinoma.对 508 名患者进行全基因组测序,确定与食管鳞状细胞癌预后不良相关的关键分子特征。
Cell Res. 2020 Oct;30(10):902-913. doi: 10.1038/s41422-020-0333-6. Epub 2020 May 12.
2
Rare Pulmonary Neuroendocrine Cells Are Stem Cells Regulated by Rb, p53, and Notch.罕见的肺神经内分泌细胞是由 Rb、p53 和 Notch 调控的干细胞。
Cell. 2019 Oct 3;179(2):403-416.e23. doi: 10.1016/j.cell.2019.09.010.
3
Concurrent RB1 and TP53 Alterations Define a Subset of EGFR-Mutant Lung Cancers at risk for Histologic Transformation and Inferior Clinical Outcomes.
一种用于原发性食管小细胞癌的新型风险分层系统:预后和分期的指征
J Natl Cancer Cent. 2025 Feb 17;5(2):212-220. doi: 10.1016/j.jncc.2025.02.003. eCollection 2025 Apr.
4
NSE and ProGRP Are Promising Markers for Diagnosis, Efficacy Evaluation, Follow-Up Monitoring, and Prognosis of Small Cell Esophageal Carcinoma.神经元特异性烯醇化酶和胃泌素释放肽前体是小细胞食管癌诊断、疗效评估、随访监测及预后的有前景的标志物。
Thorac Cancer. 2025 Feb;16(4):e70026. doi: 10.1111/1759-7714.70026.
5
Integrated bioinformatics analysis to explore potential therapeutic targets and drugs for small cell carcinoma of the esophagus.整合生物信息学分析以探索食管小细胞癌的潜在治疗靶点和药物。
Front Bioinform. 2025 Jan 28;5:1495052. doi: 10.3389/fbinf.2025.1495052. eCollection 2025.
6
Treatment strategies for limited-stage small cell carcinoma of the esophagus: evidence from a Chinese multicenter cohort study and the American SEER database.局限期食管小细胞癌的治疗策略:来自中国多中心队列研究和美国监测、流行病学和最终结果(SEER)数据库的证据
J Thorac Dis. 2024 Nov 30;16(11):7787-7796. doi: 10.21037/jtd-24-1394. Epub 2024 Nov 26.
7
Epigenetic regulation of p63 blocks squamous-to-neuroendocrine transdifferentiation in esophageal development and malignancy.表观遗传调控 p63 阻止食管发育和恶性肿瘤中的鳞状细胞向神经内分泌转化。
Sci Adv. 2024 Oct 11;10(41):eadq0479. doi: 10.1126/sciadv.adq0479. Epub 2024 Oct 9.
8
Prognostic factors and treatment strategies of limited-stage primary esophageal small-cell carcinoma-a SEER database analysis.局限期原发性食管小细胞癌的预后因素及治疗策略——一项监测、流行病学和最终结果(SEER)数据库分析
Transl Cancer Res. 2024 Jul 31;13(7):3242-3250. doi: 10.21037/tcr-24-311. Epub 2024 Jul 26.
9
Neoadjuvant chemoimmunotherapy for small cell carcinoma of the esophagus: Clinical efficacy and biomarker exploration.新辅助化疗免疫治疗食管小细胞癌:临床疗效及生物标志物探索。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2370085. doi: 10.1080/21645515.2024.2370085. Epub 2024 Jul 5.
10
Transcription factor targets to inhibit the progression of hepatocellular carcinoma via the glycine-inflammasome signaling.转录因子靶标通过甘氨酸炎症小体信号抑制肝细胞癌的进展。
Biomol Biomed. 2024 Oct 17;24(6):1606-1619. doi: 10.17305/bb.2024.10328.
同时存在 RB1 和 TP53 改变的 EGFR 突变型肺癌具有组织学转化和临床结局不良的风险。
J Thorac Oncol. 2019 Oct;14(10):1784-1793. doi: 10.1016/j.jtho.2019.06.002. Epub 2019 Jun 19.
4
MYC-Driven Small-Cell Lung Cancer is Metabolically Distinct and Vulnerable to Arginine Depletion.MYC 驱动的小细胞肺癌在代谢上具有独特性,并容易受到精氨酸耗竭的影响。
Clin Cancer Res. 2019 Aug 15;25(16):5107-5121. doi: 10.1158/1078-0432.CCR-18-4140. Epub 2019 Jun 4.
5
Durvalumab in Combination with Olaparib in Patients with Relapsed SCLC: Results from a Phase II Study.度伐利尤单抗联合奥拉帕利治疗复发性小细胞肺癌患者的疗效:一项 II 期研究结果。
J Thorac Oncol. 2019 Aug;14(8):1447-1457. doi: 10.1016/j.jtho.2019.04.026. Epub 2019 May 4.
6
A 10-year Population-based Study of the Differences between NECs and Carcinomas of the Esophagus in Terms of Clinicopathology and Survival.一项基于人群的为期10年的关于食管神经内分泌癌(NECs)与食管癌在临床病理学及生存方面差异的研究。
J Cancer. 2019 Feb 26;10(6):1520-1527. doi: 10.7150/jca.29483. eCollection 2019.
7
Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data.小细胞肺癌的分子亚型:人类和小鼠模型数据的综合。
Nat Rev Cancer. 2019 May;19(5):289-297. doi: 10.1038/s41568-019-0133-9.
8
Targeting NOTCH activation in small cell lung cancer through LSD1 inhibition.通过 LSD1 抑制靶向小细胞肺癌中的 NOTCH 激活。
Sci Signal. 2019 Feb 5;12(567):eaau2922. doi: 10.1126/scisignal.aau2922.
9
Therapeutic targeting of the RB1 pathway in retinoblastoma with the oncolytic adenovirus VCN-01.溶瘤腺病毒 VCN-01 对视网膜母细胞瘤中 RB1 通路的治疗靶向作用。
Sci Transl Med. 2019 Jan 23;11(476). doi: 10.1126/scitranslmed.aat9321.
10
A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade.肿瘤细胞程序性死亡配体 1 表达促进 T 细胞排除和对检查点阻断的抵抗
Cell. 2018 Nov 1;175(4):984-997.e24. doi: 10.1016/j.cell.2018.09.006.